Ask AI
ProCE Banner Activity

Long-Acting ART for All: Real-world Updates From CROI 2026

Conference Coverage
Clinical Thought

For me, one of the highlights of CROI 2026 was all the data about how healthcare professionals (HCPs) are actually using LA ART in the real world. Fundamentally, HCPs are now using LA ART in those with viremia and adherence challenges. I think this conference demonstrated that we have entered a new era of ART, with emphasis on long-acting agents for all. 

Released: April 03, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Disclosure

Primary Author

Monica Gandhi, MD, MPH, has no relevant financial relationships to disclose.